{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:47:10Z","timestamp":1792000030470,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T00:00:00Z","timestamp":1397088000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s10549-014-2930-x","type":"journal-article","created":{"date-parts":[[2014,4,9]],"date-time":"2014-04-09T08:07:57Z","timestamp":1397030877000},"page":"371-379","source":"Crossref","is-referenced-by-count":113,"title":["Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor\u00ae) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study"],"prefix":"10.1007","volume":"145","author":[{"given":"Gilbert","family":"Donders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Neven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Moegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneleen","family":"Lintermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Bellen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valdas","family":"Prasauskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Grob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Ortmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Buchholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,10]]},"reference":[{"issue":"24","key":"2930_CR1","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMra023246","volume":"348","author":"IE Smith","year":"2003","unstructured":"Smith IE, Dowsett M (2003) Aromatase inhibitors in breast cancer. N Engl J Med 348(24):2431\u20132442","journal-title":"N Engl J Med"},{"issue":"5","key":"2930_CR2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/01.GME.0000117061.40493.AB","volume":"11","author":"C Crandall","year":"2004","unstructured":"Crandall C, Petersen L, Ganz PA, Greendale GA (2004) Association of breast cancer and its therapy with menopause-related symptoms. Menopause 11(5):519\u2013530","journal-title":"Menopause"},{"issue":"1","key":"2930_CR3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1471-0528.2002.00432.x","volume":"109","author":"GG Donders","year":"2002","unstructured":"Donders GG, Vereecken A, Bosmans E, Dekeersmaecker A, Salembier G, Spitz B (2002) Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG 109(1):34\u201343","journal-title":"BJOG"},{"issue":"10","key":"2930_CR4","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/annonc\/mdn353","volume":"19","author":"M Hickey","year":"2008","unstructured":"Hickey M, Saunders C, Partridge A, Santoro N, Joffe H, Stearns V (2008) Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer. Ann Oncol 19(10):1669\u20131680","journal-title":"Ann Oncol"},{"issue":"17","key":"2930_CR5","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/j.ejca.2005.07.015","volume":"41","author":"R Ponzone","year":"2005","unstructured":"Ponzone R, Biglia N, Jacomuzzi ME, Maggiorotto F, Mariani L, Sismondi P (2005) Vaginal oestrogen therapy after breast cancer: is it safe? Eur J Cancer 41(17):2673\u20132681","journal-title":"Eur J Cancer"},{"issue":"3","key":"2930_CR6","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1634\/theoncologist.2007-0234","volume":"13","author":"M Trinkaus","year":"2008","unstructured":"Trinkaus M, Chin S, Wolfman W, Simmons C, Clemons M (2008) Should urogenital atrophy in breast cancer survivors be treated with topical estrogens? Oncologist 13(3):222\u2013231","journal-title":"Oncologist"},{"issue":"4","key":"2930_CR7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1471-0528.1998.tb10124.x","volume":"105","author":"L Cardozo","year":"1998","unstructured":"Cardozo L, Benness C, Abbott D (1998) Low dose oestrogen prophylaxis for recurrent urinary tract infections in elderly women. Br J Obstet Gynaecol 105(4):403\u2013407","journal-title":"Br J Obstet Gynaecol"},{"key":"2930_CR8","first-page":"CD001500","volume":"4","author":"J Suckling","year":"2006","unstructured":"Suckling J, Lethaby A, Kennedy R (2006) Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 4:CD001500","journal-title":"Cochrane Database Syst Rev"},{"key":"2930_CR9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0378-5122(95)00955-8","volume":"23","author":"M Bygdeman","year":"1996","unstructured":"Bygdeman M, Swahn ML (1996) Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women. Maturitas 23:259\u2013263","journal-title":"Maturitas"},{"issue":"3","key":"2930_CR10","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1200\/JCO.1997.15.3.969","volume":"15","author":"CL Loprinzi","year":"1997","unstructured":"Loprinzi CL, Abu-Ghazaleh S, Sloan JA, vanHaelst-Pisani C, Hammer AM, Rowland KM Jr et al (1997) Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer. J Clin Oncol 15(3):969\u2013973","journal-title":"J Clin Oncol"},{"issue":"1","key":"2930_CR11","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0015-0282(16)56474-7","volume":"61","author":"LE Nachtigall","year":"1994","unstructured":"Nachtigall LE (1994) Comparative study: Replens versus local estrogen in menopausal women. Fertil Steril 61(1):178\u2013180","journal-title":"Fertil Steril"},{"issue":"4","key":"2930_CR12","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/annonc\/mdj127","volume":"17","author":"A Kendall","year":"2006","unstructured":"Kendall A, Dowsett M, Folkerd E, Smith I (2006) Caution: vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors. Ann Oncol 17(4):584\u2013587","journal-title":"Ann Oncol"},{"issue":"7","key":"2930_CR13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djn058","volume":"100","author":"L Holmberg","year":"2008","unstructured":"Holmberg L, Iversen OE, Rudenstam CM, Hammar M, Kumpulainen E, Jaskiewicz J et al (2008) Increased risk of recurrence after hormone replacement therapy in breast cancer survivors. J Natl Cancer Inst 100(7):475\u2013482","journal-title":"J Natl Cancer Inst"},{"issue":"9407","key":"2930_CR14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(04)15493-7","volume":"363","author":"L Holmberg","year":"2004","unstructured":"Holmberg L, Anderson H (2004) HABITS (hormonal replacement therapy after breast cancer\u2014is it safe?), a randomised comparison: trial stopped. Lancet 363(9407):453\u2013455","journal-title":"Lancet"},{"key":"2930_CR15","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3109\/09513591003632258","volume":"26","author":"N Biglia","year":"2010","unstructured":"Biglia N, Peano E, Sgandurra P, Moggio G, Panuccio E, Migliardi M et al (2010) Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study. Gynecol Endocrinol 26:404\u2013412","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"2930_CR16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/gme.0b013e31817b6132","volume":"16","author":"F Labrie","year":"2009","unstructured":"Labrie F, Cusan L, Gomez JL, Cote I, Berube R, Belanger P et al (2009) Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women. Menopause 16(1):30\u201336","journal-title":"Menopause"},{"issue":"4","key":"2930_CR17","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0029-7844(01)01385-0","volume":"99","author":"M Notelovitz","year":"2002","unstructured":"Notelovitz M, Funk S, Nanavati N, Mazzeo M (2002) Estradiol absorption from vaginal tablets in postmenopausal women. Obstet Gynecol 99(4):556\u2013562","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2930_CR18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00042192-200205000-00006","volume":"9","author":"RJ Santen","year":"2002","unstructured":"Santen RJ, Pinkerton JV, Conaway M, Ropka M, Wisniewski L, Demers L et al (2002) Treatment of urogenital atrophy with low-dose estradiol: preliminary results. Menopause 9(3):179\u2013187","journal-title":"Menopause"},{"issue":"2","key":"2930_CR19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/13697130802585576","volume":"12","author":"O Al-Baghdadi","year":"2009","unstructured":"Al-Baghdadi O, Ewies AA (2009) Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview. Climacteric 12(2):91\u2013105","journal-title":"Climacteric"},{"key":"2930_CR20","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00404-011-2181-6","volume":"285","author":"M Moegele","year":"2012","unstructured":"Moegele M, Buchholz S, Seitz S, Ortmann O (2012) Vaginal estrogen therapy in postmenopausal breast cancer patients treated with aromatase inhibitors. Arch Gynecol Obstet 285:1397\u20131402","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"2930_CR21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/09513590.2012.705389","volume":"29","author":"L Mariani","year":"2013","unstructured":"Mariani L, Gadducci A, Vizza E, Tomao S, Vici P (2013) Vaginal atrophy in breast cancer survivors: role of vaginal estrogen therapy. Gynecol Endocrinol 29(1):25\u201329","journal-title":"Gynecol Endocrinol"},{"issue":"9","key":"2930_CR22","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3109\/09513590.2011.652717","volume":"28","author":"PL Del","year":"2012","unstructured":"Del PL (2012) Management of vaginal dryness and dyspareunia in estrogen sensitive cancer patients. Gynecol Endocrinol 28(9):740\u2013745","journal-title":"Gynecol Endocrinol"},{"key":"2930_CR23","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1097\/gme.0b013e3181a06c80","volume":"16","author":"JA Chollet","year":"2009","unstructured":"Chollet JA (2009) Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis. Menopause 16:978\u2013983","journal-title":"Menopause"},{"issue":"4","key":"2930_CR24","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1159\/000314016","volume":"70","author":"GG Donders","year":"2010","unstructured":"Donders GG, Van BB, Van de WP, Kaiser RR, Pohlig G, Gonser S et al (2010) Effect of lyophilized lactobacilli and 0.03\u00a0mg estriol (Gynoflor(R)) on vaginitis and vaginosis with disrupted vaginal microflora: a multicenter, randomized, single-blind, active-controlled pilot study. Gynecol Obstet Invest 70(4):264\u2013272","journal-title":"Gynecol Obstet Invest"},{"issue":"2","key":"2930_CR25","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1471-0528.2004.00329.x","volume":"112","author":"E Ozkinay","year":"2005","unstructured":"Ozkinay E, Terek MC, Yayci M, Kaiser R, Grob P, Tuncay G (2005) The effectiveness of live lactobacilli in combination with low dose oestriol (Gynoflor) to restore the vaginal flora after treatment of vaginal infections. BJOG 112(2):234\u2013240","journal-title":"BJOG"},{"key":"2930_CR26","first-page":"35","volume":"3","author":"B Kanne","year":"1986","unstructured":"Kanne B, Patz B, Wackerle L (1986) Local treatment of vaginal infections with Doederlein bacteria and estriol in climacterium and senium. Frauenarzt 3:35\u201340","journal-title":"Frauenarzt"},{"issue":"Supplement","key":"2930_CR27","first-page":"134","volume":"246","author":"B Kanne","year":"1989","unstructured":"Kanne B (1989) Local administration of weakly dosed estriol and active Lactobacillus acidophilus in the postmenopausal period. Arch Gynecol Obstet 246(Supplement):134","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"2930_CR28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000271609","volume":"31","author":"B Kanne","year":"1991","unstructured":"Kanne B, Jenny J (1991) Local administration of low-dosed estriol and viable Lactobacillus acidophilus in the post-menopausal period. Gyn\u00e4kol Rundsch 31(1):7\u201313","journal-title":"Gyn\u00e4kol Rundsch"},{"issue":"3","key":"2930_CR29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3109\/13697137.2013.769097","volume":"16","author":"U Jaisamrarn","year":"2013","unstructured":"Jaisamrarn U, Triratanachat S, Chaikittisilpa S, Grob P, Prasauskas V, Taechakraichana N (2013) Ultra-low-dose estriol and lactobacilli in the local treatment of postmenopausal vaginal atrophy. Climacteric 16(3):347\u2013355","journal-title":"Climacteric"},{"key":"2930_CR30","first-page":"2","volume":"3","author":"RR Kaiser","year":"2000","unstructured":"Kaiser RR, Michael-Hepp J, Weber W, Graf F, Lauritzen C (2000) Absorption of estriol from vaginal tablets after single and repeated application in healthy, postmenopausal women. Therapiewoche 3:2\u20138","journal-title":"Therapiewoche"},{"issue":"2","key":"2930_CR31","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejogrb.2006.07.016","volume":"134","author":"GG Donders","year":"2007","unstructured":"Donders GG, Caeyers T, Tydhof P, Riphagen I, Van den Bosch T, Bellen G (2007) Comparison of two types of dipsticks to measure vaginal pH in clinical practice. Eur J Obstet Gynecol Reprod Biol 134(2):220\u2013224","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"2930_CR32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/(SICI)1098-0997(1999)7:4<177::AID-IDOG2>3.0.CO;2-6","volume":"7","author":"GG Donders","year":"1999","unstructured":"Donders GG (1999) Microscopy of the bacterial flora on fresh vaginal smears. Infect Dis Obstet Gynecol 7(4):177\u2013179","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"3","key":"2930_CR33","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bpobgyn.2007.01.002","volume":"21","author":"GG Donders","year":"2007","unstructured":"Donders GG (2007) Definition and classification of abnormal vaginal flora. Best Pract Res Clin Obstet Gynaecol 21(3):355\u2013373","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"3\u20135","key":"2930_CR34","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jsbmb.2007.09.017","volume":"108","author":"PE Lonning","year":"2008","unstructured":"Lonning PE, Geisler J (2008) Aromatase inhibitors: assessment of biochemical efficacy measured by total body aromatase inhibition and tissue estrogen suppression. J Steroid Biochem Mol Biol 108(3\u20135):196\u2013202","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"4\u20135","key":"2930_CR35","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.steroids.2010.01.012","volume":"75","author":"IA Blair","year":"2010","unstructured":"Blair IA (2010) Analysis of estrogens in serum and plasma from postmenopausal women: past present, and future. Steroids 75(4\u20135):297\u2013306","journal-title":"Steroids"},{"issue":"3","key":"2930_CR36","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1200\/JOP.2011.000352","volume":"8","author":"S Wills","year":"2012","unstructured":"Wills S, Ravipati A, Venuturumilli P, Kresge C, Folkerd E, Dowsett M et al (2012) Effects of vaginal estrogens on serum estradiol levels in postmenopausal breast cancer survivors and women at risk of breast cancer taking an aromatase inhibitor or a selective estrogen receptor modulator. J Oncol Pract 8(3):144\u2013148","journal-title":"J Oncol Pract"},{"key":"2930_CR37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000269026","volume":"20","author":"PJ Keller","year":"1980","unstructured":"Keller PJ, Riedmann R, Fischer M (1980) Oestrone, oestradiol and oestriol content following intravaginal application of oestriol in the postmenopause. Gyn\u00e4kol Rundsch 20:77\u201379","journal-title":"Gyn\u00e4kol Rundsch"},{"key":"2930_CR38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/00016348309154209","volume":"62","author":"L-A Mattsson","year":"1983","unstructured":"Mattsson L-A, Cullberg G (1983) A clinical evaluation of treatment with estriol vaginal cream versus suppository in postmenopausal women. Acta Obstet Gynecol Scand 62:397\u2013401","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4A","key":"2930_CR39","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0022-4731(89)90055-1","volume":"33","author":"M Haaften van","year":"1989","unstructured":"van Haaften M, Donker GH, Haspels AA, Thijssen JHH (1989) Oestrogen concentrations in plasma, endometrium, myometrium and vagina of postmenopausal women, and effects of vaginal oestriol (E3) and oestradiol (E2) applications. J Steroid Biochem 33(4A):647\u2013653","journal-title":"J Steroid Biochem"},{"issue":"10","key":"2930_CR40","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/jnci\/93.10.754","volume":"93","author":"ES O\u2019Meara","year":"2001","unstructured":"O\u2019Meara ES, Rossing MA, Daling JR, Elmore JG, Barlow WE, Weiss NS (2001) Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality. J Natl Cancer Inst 93(10):754\u2013762","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"2930_CR41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/713605341","volume":"6","author":"JE Dew","year":"2003","unstructured":"Dew JE, Wren BG, Eden JA (2003) A cohort study of topical vaginal estrogen therapy in women previously treated for breast cancer. Climacteric 6(1):45\u201352","journal-title":"Climacteric"},{"issue":"6","key":"2930_CR42","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1097\/01.AOG.0000241091.86268.6e","volume":"108","author":"H Lyytinen","year":"2006","unstructured":"Lyytinen H, Pukkala E, Ylikorkala O (2006) Breast cancer risk in postmenopausal women using estrogen-only therapy. Obstet Gynecol 108(6):1354\u20131360","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2930_CR43","first-page":"101","volume":"3","author":"KA Head","year":"1998","unstructured":"Head KA (1998) Estriol: safety and efficacy. Altern Med Rev 3(2):101\u2013113","journal-title":"Altern Med Rev"},{"key":"2930_CR44","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0378-5122(82)90061-5","volume":"4","author":"J Vies van der","year":"1982","unstructured":"van der Vies J (1982) The pharmacology of oestriol. Maturitas 4:291\u2013299","journal-title":"Maturitas"},{"key":"2930_CR45","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1210\/endo-96-1-160","volume":"96","author":"JN Anderson","year":"1975","unstructured":"Anderson JN, Peck EJJ, Clark JH (1975) Estrogen-induced uterine responses and growth: relationship to receptor estrogen binding by uterine nuclei. Endocrinology 96:160\u2013167","journal-title":"Endocrinology"},{"key":"2930_CR46","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3109\/00016348409156720","volume":"63","author":"G Heimer","year":"1984","unstructured":"Heimer G, Englund D (1984) Estriol: absorption after long-term vaginal treatment and gastrointestinal absorption as influenced by a meal. Acta Obstet Gynecol Scand 63:563\u2013567","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"8","key":"2930_CR47","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1055\/s-0032-1314822","volume":"62","author":"KJ Buhling","year":"2012","unstructured":"Buhling KJ, Eydeler U, Borregaard S, Schlegelmilch R, Suesskind M (2012) Systemic bioavailability of estriol following single and repeated vaginal administration of 0.03\u00a0mg estriol containing pessaries. Arzneimittelforschung 62(8):378\u2013383","journal-title":"Arzneimittelforschung"},{"issue":"2","key":"2930_CR48","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.steroids.2012.10.014","volume":"78","author":"C Lattrich","year":"2013","unstructured":"Lattrich C, Stegerer A, Haring J, Schuler S, Ortmann O, Treeck O (2013) Estrogen receptor beta agonists affect growth and gene expression of human breast cancer cell lines. Steroids 78(2):195\u2013202","journal-title":"Steroids"},{"issue":"Suppl 1","key":"2930_CR49","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.3747\/co.2007.151","volume":"14","author":"C Derzko","year":"2007","unstructured":"Derzko C, Elliott S, Lam W (2007) Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy. Curr Oncol 14(Suppl 1):S20\u2013S40","journal-title":"Curr Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-014-2930-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-014-2930-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-014-2930-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T04:25:46Z","timestamp":1648787146000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-014-2930-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,10]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["2930"],"URL":"https:\/\/doi.org\/10.1007\/s10549-014-2930-x","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,10]]}}}